Relief Therapeutics Holding AG (RLF.SW) SIX

2.89

+0.025(+0.87%)

Updated at December 16, 2025 07:56AM

Currency In CHF

Valuation

Market Cap52.79M
Enterprise Value39.86M
P/E RatioN/A
PEG RatioN/A
Price/Sales RatioN/A
Price/Book RatioN/A
Enterprise/RevenueN/A
Enterprise/EBITDAN/A

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit MarginN/A
Operating MarginN/A

Management Effectiveness

Return On AssetsN/A
Return On EquityN/A

Income Statement

Revenue8.42M
Revenue/ShareN/A
Gross Profit5.84M
EBITDA-16.73M
Net Income-17.12M
Diluted EPS-1.36

Balance Sheet

Total Cash12.5M
Total Cash/ShareN/A
Total Debt1.9M
Total Debt/EquityN/A
Current RatioN/A
Book Value Per ShareN/A

Price History

52-Week Change-27.15
52-Week High4.59
52-Week Low1.65
Moving Average 50 Days2.91
Moving Average 200 Days2.61

Statistics

Average Volume41,210
Shares Outstanding12.58M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend RateN/A
Trailing Annual Dividend YieldN/A
Payout RatioN/A
Last Split Factor1:400
Last Split DateMay 05, 2023